Financings in Brief: Rochester Medical
This article was originally published in The Gray Sheet
Executive Summary
Rochester Medical: Registration is filed with the Securities and Exchange Commission for a secondary offering of 1.3 mil. shares of common stock to "selected institutional investors." A portion of the proceeds are tabbed for development and commercialization of the Stewartville, Minnesota firm's antibacterial Foley catheter and FemSoft insert for management of female stress incontinence. The remainder of the funds will be used for scale-up of manufacturing facilities, sales force expansion, R&D and for "working capital and other corporate purposes." Vector Securities International is the placement agent for the securities...